Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bourdin (Montpellier, France), C. Chenivesse (Lille, France), A. Didier (Toulouse, France), C. Touboul (Paris, France), M. (Toulon, France), L. Portel (Libourne, France). QUALAS: QUAlity of Life and burden in ASthma, a comparison between uncontrolled severe asthma and controlled moderate/severe asthma. 4251

Member's Comments

No comment yet.

Related content which might interest you: Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Current burden of uncontrolled asthma in the general population: The OPCRD asthma state of the union study Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Factors influencing to HRQOL of patients with mild to moderate persistent asthma in Japan; sub-analysis of GAIA study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Effect of tralokinumab on GINA control in severe, uncontrolled asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Clinical characteristics and burden of illness in a cohort of severe asthma patients Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016 Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study Source: International Congress 2017 – Asthma management Year: 2017 Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Sleep quality in patients with asthma and COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Association of asthma admissions and health related quality of life (HRQoL), asthma control and severity Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015